找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

(版塊PHARMACOLOGY & PHARMACY(藥理學(xué)與藥學(xué))版塊期刊總數(shù):80)
1234下一頁(yè)
返 回
新窗
投票 ESCI期刊Journal of Pharmaceutical Policy and Practice 2024/2025影響因子:3.391 (J PHARM POLICY PRACT) (NULL). (PHARMACOLOGY &  ...234
Total Citations:1370; 2023 JIF:3.391; JIFRank: 118/354 ; Rank-JIF: 118; Number-of-JIF:354; 5 Year JIF:3.772; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3; Immediacy Index:0.6; Immediacy Index-dealt:0.624; 2023 JCI:0.96; JCI Rank: 91/354 ; Total Articles:143; JCI Quartile:Q2; JCI Percentile:74.44; Eigenfactor:0.002; Normalized Eigenfactor:0.442; Article Influence Score:0.835; JIF Percentile:66.8; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:163; % of Articles in Citable items:0.8773; Cited Half-Life:3; Citing Half-Life:6; % of OA Gold:1; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊SCIENTIA PHARMACEUTICA 2024/2025影響因子:2.363 (SCI PHARM) (NULL). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Emerging Sources  ...234
Total Citations:1840; 2023 JIF:2.363; JIFRank: 199/354 ; Rank-JIF: 199; Number-of-JIF:354; 5 Year JIF:2.921; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.2; Immediacy Index:0.9; Immediacy Index-dealt:0.924; 2023 JCI:0.67; JCI Rank: 171/354 ; Total Articles:41; JCI Quartile:Q2; JCI Percentile:51.84; Eigenfactor:0.001; Normalized Eigenfactor:0.19; Article Influence Score:0.397; JIF Percentile:43.9; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:55; % of Articles in Citable items:0.7455; Cited Half-Life:6.9; Citing Half-Life:7.7; % of OA Gold:1; Publisher name:TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON PARK, ABINGDON, E
投票 ESCI期刊Expert Review of Precision Medicine and Drug Development 2024/2025影響因子:1.122 (EXPERT REV PRECIS ME) (2380-8993).  ...234
Total Citations:251; 2023 JIF:1.122; JIFRank: 301/354 ; Rank-JIF: 301; Number-of-JIF:354; 5 Year JIF:1.377; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1; Immediacy Index:<0.1; Immediacy Index-dealt:0.006; 2023 JCI:0.16; JCI Rank: 327/354 ; Total Articles:0; JCI Quartile:Q4; JCI Percentile:7.77; Eigenfactor:0; Normalized Eigenfactor:0.066; Article Influence Score:0.304; JIF Percentile:15.1; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:2; % of Articles in Citable items:0; Cited Half-Life:5; Citing Half-Life:6.1; % of OA Gold:0.175; Publisher name:CURRENT MEDICINE GROUP; Publisher address:400 MARKET STREET, STE 700, PHILADELPHIA, USA, PA,
投票 ESCI期刊Current Reviews in Clinical and Experimental Pharmacology 2024/2025影響因子:1.329 (CURR REV CLIN EXP PH) (2772-4328).  ...234
Total Citations:107; 2023 JIF:1.329; JIFRank: 283/354 ; Rank-JIF: 283; Number-of-JIF:354; 5 Year JIF:1.337; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.3; Immediacy Index:1; Immediacy Index-dealt:1.183; 2023 JCI:0.41; JCI Rank: 267/354 ; Total Articles:3; JCI Quartile:Q4; JCI Percentile:24.72; Eigenfactor:0; Normalized Eigenfactor:0.032; Article Influence Score:0.269; JIF Percentile:20.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:22; % of Articles in Citable items:0.1364; Cited Half-Life:1.8; Citing Half-Life:11; % of OA Gold:0.0455; Publisher name:NULL; Publisher address:NULL;
投票 ESCI期刊Asian Journal of Pharmaceutical Research and Health Care 2024/2025影響因子:0.203 (ASIAN J PHARM RES HE) (2250-1444).  ...234
Total Citations:81; 2023 JIF:0.203; JIFRank: 350/354 ; Rank-JIF: 350; Number-of-JIF:354; 5 Year JIF:0.253; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.1; Immediacy Index:<0.1; Immediacy Index-dealt:0.033; 2023 JCI:0.08; JCI Rank: 344/354 ; Total Articles:56; JCI Quartile:Q4; JCI Percentile:2.97; Eigenfactor:0; Normalized Eigenfactor:0.008; Article Influence Score:0.036; JIF Percentile:1.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:61; % of Articles in Citable items:0.918; Cited Half-Life:NULL; Citing Half-Life:8.6; % of OA Gold:0.9771; Publisher name:LIPPINCOTT WILLIAMS & WILKINS; Publisher address:TWO COMMERCE SQ, 2001 MARKET ST,
投票 ESCI期刊Advances in Pharmacology and Pharmacy 2024/2025影響因子:0.445 (ADV PHARMACOL PHARM) (2332-0036). (PHARMACOLOGY & PHAR  ...234
Total Citations:77; 2023 JIF:0.445; JIFRank: 335/354 ; Rank-JIF: 335; Number-of-JIF:354; 5 Year JIF:0.515; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:0.5; Immediacy Index-dealt:0.599; 2023 JCI:0.11; JCI Rank: 337/354 ; Total Articles:27; JCI Quartile:Q4; JCI Percentile:4.94; Eigenfactor:0; Normalized Eigenfactor:0.008; Article Influence Score:0.058; JIF Percentile:5.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:31; % of Articles in Citable items:0.871; Cited Half-Life:NULL; Citing Half-Life:10.4; % of OA Gold:1; Publisher name:ELSEVIER; Publisher address:RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX;
投票 ESCI期刊FARMACIA HOSPITALARIA 2024/2025影響因子:1.179 (FARM HOSP) (1130-6343). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Emerging Sour  ...234
Total Citations:529; 2023 JIF:1.179; JIFRank: 301/354 ; Rank-JIF: 301; Number-of-JIF:354; 5 Year JIF:1.325; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.8; Immediacy Index:0.1; Immediacy Index-dealt:0.191; 2023 JCI:0.32; JCI Rank: 290/354 ; Total Articles:71; JCI Quartile:Q4; JCI Percentile:18.22; Eigenfactor:0.001; Normalized Eigenfactor:0.118; Article Influence Score:0.289; JIF Percentile:15.1; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:85; % of Articles in Citable items:0.8353; Cited Half-Life:4.9; Citing Half-Life:6.7; % of OA Gold:0.3979; Publisher name:HERPETOLOGICAL SOC JAPAN, KYOTO UNIV, GRADUATE SCH SCIE; Publisher address:D
投票 ESCI期刊Advanced Pharmaceutical Bulletin 2024/2025影響因子:3.164 (ADV PHARM BULL) (2228-5881). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與  ...234
Total Citations:3318; 2023 JIF:3.164; JIFRank: 126/354 ; Rank-JIF: 126; Number-of-JIF:354; 5 Year JIF:4.386; 5 Year JIF Quartile:Q1; JIF Without Self Cites:3; Immediacy Index:0.6; Immediacy Index-dealt:0.648; 2023 JCI:0.84; JCI Rank: 116/354 ; Total Articles:48; JCI Quartile:Q2; JCI Percentile:67.37; Eigenfactor:0.002; Normalized Eigenfactor:0.431; Article Influence Score:0.605; JIF Percentile:64.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:79; % of Articles in Citable items:0.6076; Cited Half-Life:5.7; Citing Half-Life:7.3; % of OA Gold:0.7983; Publisher name:PERGAMON-ELSEVIER SCIENCE LTD; Publisher address:THE BOULEVARD, LANGFORD LANE
投票 ESCI期刊Drug Discoveries and Therapeutics 2024/2025影響因子:1.937 (DRUG DISCOV THER) (1881-7831). (PHARMACOLOGY & PHARMACY)(藥  ...234
Total Citations:1088; 2023 JIF:1.937; JIFRank: 231/354 ; Rank-JIF: 231; Number-of-JIF:354; 5 Year JIF:1.867; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.7; Immediacy Index:0.2; Immediacy Index-dealt:0.257; 2023 JCI:0.93; JCI Rank: 95/354 ; Total Articles:53; JCI Quartile:Q2; JCI Percentile:73.31; Eigenfactor:0.001; Normalized Eigenfactor:0.178; Article Influence Score:0.356; JIF Percentile:34.9; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:64; % of Articles in Citable items:0.8281; Cited Half-Life:6.5; Citing Half-Life:7; % of OA Gold:0.9451; Publisher name:CAMBRIDGE UNIV PRESS; Publisher address:EDINBURGH BLDG, SHAFTESBURY RD, CAMBRI
投票 ESCI期刊SA Pharmaceutical Journal 2024/2025影響因子:0.284 (SA PHARM J) (2221-5875). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Emerging  ...234
Total Citations:62; 2023 JIF:0.284; JIFRank: 350/354 ; Rank-JIF: 350; Number-of-JIF:354; 5 Year JIF:0.239; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.2; Immediacy Index:<0.1; Immediacy Index-dealt:0.083; 2023 JCI:0.01; JCI Rank: 354/354 ; Total Articles:7; JCI Quartile:Q4; JCI Percentile:0.14; Eigenfactor:0; Normalized Eigenfactor:0.009; Article Influence Score:0.039; JIF Percentile:1.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:32; % of Articles in Citable items:0.2188; Cited Half-Life:NULL; Citing Half-Life:7.3; % of OA Gold:0; Publisher name:PERGAMON-ELSEVIER SCIENCE LTD; Publisher address:THE BOULEVARD, LANGFORD LANE, KIDLINGT
投票 ESCI期刊Drug Research 2024/2025影響因子:1.753 (DRUG RES) (2194-9379). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Emerging Sources Citat  ...234
Total Citations:1447; 2023 JIF:1.753; JIFRank: 251/354 ; Rank-JIF: 251; Number-of-JIF:354; 5 Year JIF:1.848; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.6; Immediacy Index:0.6; Immediacy Index-dealt:0.677; 2023 JCI:0.36; JCI Rank: 278/354 ; Total Articles:30; JCI Quartile:Q4; JCI Percentile:21.61; Eigenfactor:0.001; Normalized Eigenfactor:0.201; Article Influence Score:0.283; JIF Percentile:29.2; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:46; % of Articles in Citable items:0.6522; Cited Half-Life:5.9; Citing Half-Life:8.5; % of OA Gold:0.0375; Publisher name:OXFORD UNIV PRESS; Publisher address:GREAT CLARENDON ST, OXFORD, ENGLAND, O
投票 ESCI期刊Journal of Young Pharmacists 2024/2025影響因子:0.486 (J YOUNG PHARM) (0975-1483). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Em  ...234
Total Citations:910; 2023 JIF:0.486; JIFRank: 335/354 ; Rank-JIF: 335; Number-of-JIF:354; 5 Year JIF:0.697; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.4; Immediacy Index:0.1; Immediacy Index-dealt:0.148; 2023 JCI:0.1; JCI Rank: 341/354 ; Total Articles:72; JCI Quartile:Q4; JCI Percentile:3.81; Eigenfactor:0; Normalized Eigenfactor:0.073; Article Influence Score:0.078; JIF Percentile:5.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:87; % of Articles in Citable items:0.8276; Cited Half-Life:8.8; Citing Half-Life:8.4; % of OA Gold:0.871; Publisher name:INT JOURNAL PARTICLE THERAPY; Publisher address:2000 SW ARCHER RD, GAINESVILLE, Unit
投票 ESCI期刊Research Journal of Pharmacognosy 2024/2025影響因子:1.108 (RES J PHARMACOGN) (2345-4458). (PHARMACOLOGY & PHARMACY)(藥  ...234
Total Citations:436; 2023 JIF:1.108; JIFRank: 296/354 ; Rank-JIF: 296; Number-of-JIF:354; 5 Year JIF:1.195; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1; Immediacy Index:0.2; Immediacy Index-dealt:0.224; 2023 JCI:0.25; JCI Rank: 303/354 ; Total Articles:29; JCI Quartile:Q4; JCI Percentile:14.55; Eigenfactor:0; Normalized Eigenfactor:0.05; Article Influence Score:0.142; JIF Percentile:16.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:35; % of Articles in Citable items:0.8286; Cited Half-Life:6; Citing Half-Life:7.3; % of OA Gold:0; Publisher name:BMJ PUBLISHING GROUP; Publisher address:BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON,
投票 ESCI期刊Therapeutic Delivery 2024/2025影響因子:3.157 (THER DELIV) (2041-5990). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Emerging Sour  ...234
Total Citations:2566; 2023 JIF:3.157; JIFRank: 136/354 ; Rank-JIF: 136; Number-of-JIF:354; 5 Year JIF:3.762; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.5; Immediacy Index:0.6; Immediacy Index-dealt:0.686; 2023 JCI:0.7; JCI Rank: 163/354 ; Total Articles:27; JCI Quartile:Q2; JCI Percentile:54.1; Eigenfactor:0.001; Normalized Eigenfactor:0.206; Article Influence Score:0.535; JIF Percentile:61.7; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:53; % of Articles in Citable items:0.5094; Cited Half-Life:7.8; Citing Half-Life:7.5; % of OA Gold:0.094; Publisher name:CAMBRIDGE UNIV PRESS; Publisher address:EDINBURGH BLDG, SHAFTESBURY RD, CAMBRI
投票 ESCI期刊JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2024/2025影響因子:1.179 (J PHARM PRACT RES) (1445-937X). (PHARMACOLOGY & PH  ...234
Total Citations:546; 2023 JIF:1.179; JIFRank: 301/354 ; Rank-JIF: 301; Number-of-JIF:354; 5 Year JIF:NULL; 5 Year JIF Quartile:NULL; JIF Without Self Cites:0.9; Immediacy Index:0.1; Immediacy Index-dealt:0.163; 2023 JCI:0.22; JCI Rank: 309/354 ; Total Articles:33; JCI Quartile:Q4; JCI Percentile:12.85; Eigenfactor:0.001; Normalized Eigenfactor:0.501; Article Influence Score:0.313; JIF Percentile:15.1; JIF Quartile:Q4; AIS Quartile:NULL; Citable Items:41; % of Articles in Citable items:0.8049; Cited Half-Life:5.7; Citing Half-Life:6; % of OA Gold:0.2721; Publisher name:INDERSCIENCE ENTERPRISES LTD; Publisher address:WORLD TRADE CENTER BLDG, 29
投票 ESCI期刊Pharmacy & Pharmacology-Farmatsiya i Farmakologiya 2024/2025影響因子:0.573 (PHARM PHARMACOL-RUSS) (2307-9266). (PHARM  ...234
Total Citations:345; 2023 JIF:0.573; JIFRank: 331/354 ; Rank-JIF: 331; Number-of-JIF:354; 5 Year JIF:0.522; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.4; Immediacy Index:0.4; Immediacy Index-dealt:0.438; 2023 JCI:0.09; JCI Rank: 343/354 ; Total Articles:26; JCI Quartile:Q4; JCI Percentile:3.25; Eigenfactor:0; Normalized Eigenfactor:0.022; Article Influence Score:0.06; JIF Percentile:6.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:34; % of Articles in Citable items:0.7647; Cited Half-Life:9.1; Citing Half-Life:4.6; % of OA Gold:0.9835; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON
投票 ESCI期刊Clinical Pharmacology-Advances and Applications 2024/2025影響因子:3.192 (CLIN PHARMACOL-ADV A) (1179-1438). (PHARMACO  ...234
Total Citations:529; 2023 JIF:3.192; JIFRank: 126/354 ; Rank-JIF: 126; Number-of-JIF:354; 5 Year JIF:2.601; 5 Year JIF Quartile:Q3; JIF Without Self Cites:3.1; Immediacy Index:0.3; Immediacy Index-dealt:0.308; 2023 JCI:0.51; JCI Rank: 232/354 ; Total Articles:7; JCI Quartile:Q3; JCI Percentile:34.6; Eigenfactor:0; Normalized Eigenfactor:0.107; Article Influence Score:0.665; JIF Percentile:64.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:11; % of Articles in Citable items:0.6364; Cited Half-Life:6.7; Citing Half-Life:7.9; % of OA Gold:1; Publisher name:SPRINGER HEIDELBERG; Publisher address:TIERGARTENSTRASSE 17, HEIDELBERG, GERMANY, D-691
投票 ESCI期刊Advances in Traditional Medicine 2024/2025影響因子:1.853 (ADV TRADIT MED) (2662-4052). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與  ...234
Total Citations:564; 2023 JIF:1.853; JIFRank: 240/354 ; Rank-JIF: 240; Number-of-JIF:354; 5 Year JIF:1.793; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:0.2; Immediacy Index-dealt:0.283; 2023 JCI:0.4; JCI Rank: 270/354 ; Total Articles:35; JCI Quartile:Q4; JCI Percentile:23.87; Eigenfactor:0.001; Normalized Eigenfactor:0.117; Article Influence Score:0.226; JIF Percentile:32.3; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:52; % of Articles in Citable items:0.6731; Cited Half-Life:3; Citing Half-Life:8.5; % of OA Gold:0.049; Publisher name:SAGE PUBLICATIONS INC; Publisher address:2455 TELLER RD, THOUSAND OAKS, USA, CA,
投票 ESCI期刊Indonesian Journal of Pharmacy 2024/2025影響因子:0.782 (INDONES J PHARM) (2338-9486). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥  ...234
Total Citations:249; 2023 JIF:0.782; JIFRank: 317/354 ; Rank-JIF: 317; Number-of-JIF:354; 5 Year JIF:0.713; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.6; Immediacy Index:0.1; Immediacy Index-dealt:0.158; 2023 JCI:0.11; JCI Rank: 337/354 ; Total Articles:44; JCI Quartile:Q4; JCI Percentile:4.94; Eigenfactor:0; Normalized Eigenfactor:0.031; Article Influence Score:0.082; JIF Percentile:10.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:45; % of Articles in Citable items:0.9778; Cited Half-Life:4.6; Citing Half-Life:6.8; % of OA Gold:0.4014; Publisher name:EUROPEAN RESPIRATORY SOC JOURNALS LTD; Publisher address:442 GLOSSOP RD, SHEFFIEL
投票 ESCI期刊Journal of Cannabis Research 2024/2025影響因子:4.172 (J CANNABIS RES) (NULL). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Emergi  ...234
Total Citations:615; 2023 JIF:4.172; JIFRank: 78/354 ; Rank-JIF: 78; Number-of-JIF:354; 5 Year JIF:3.875; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.9; Immediacy Index:1; Immediacy Index-dealt:1.141; 2023 JCI:0.97; JCI Rank: 88/354 ; Total Articles:32; JCI Quartile:Q1; JCI Percentile:75.28; Eigenfactor:0.001; Normalized Eigenfactor:0.241; Article Influence Score:0.869; JIF Percentile:78.1; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:35; % of Articles in Citable items:0.9143; Cited Half-Life:2.4; Citing Half-Life:5.6; % of OA Gold:1; Publisher name:AMER INST MATHEMATICAL SCIENCES-AIMS; Publisher address:PO BOX 2604, SPRINGFIELD, Unit
下一頁(yè) »
1234下一頁(yè)
返 回
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 08:46
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
返回頂部 返回版塊
云南省| 昌江| 喀喇沁旗| 台北市| 杭锦旗| 南投市| 疏附县| 井冈山市| 黎川县| 汝阳县| 兴隆县| 个旧市| 北安市| 巴彦县| 天峨县| 仪陇县| 甘孜县| 会东县| 龙门县| 瑞昌市| 闽清县| 东城区| 德阳市| 济南市| 青铜峡市| 阿克苏市| 五指山市| 十堰市| 常山县| 阜新| 饶平县| 康保县| 大悟县| 黄陵县| 讷河市| 进贤县| 揭阳市| 武宣县| 华蓥市| 敦化市| 博白县|